Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
08/2004
08/31/2004US6784173 Aromatic dicarboxylic acid derivatives
08/31/2004US6784137 6-aryl-4-aminopicolinates and their use as herbicides
08/26/2004WO2004072089A1 Salts comprising cyanoborate anions
08/26/2004WO2004072087A2 Metal complexes as light-absorbing compounds in the information layer of optical data carriers
08/26/2004WO2004072066A1 Tri(cyclo) substituted amide glucokinase activator compounds
08/26/2004WO2004072039A1 Novel crystalline modification of the anhydrate of boscalid
08/26/2004WO2004072038A1 Processes for the preparation of n-heteroaryl-n-aryl-amines by reacting an n-aryl carbamic acid ester with a halo-heteroaryl and analogous processes
08/26/2004WO2004072037A1 2,3'-bipyridines derivatives as selective cox-2 inhibitors
08/26/2004WO2004072031A2 Phenylacetamides and their use as glucokinase modulators
08/26/2004WO2004072026A2 Process for preparing pyridine-substituted amino ketal derivatives
08/26/2004WO2004072017A1 Cetylpyridinium salt of an anti-inflammatory agent and pharmaceutical compositions containing it
08/26/2004WO2004071445A2 2-(aminomethyl)arylamide analgesics
08/26/2004WO2004071442A2 Novel bicyclic compounds and compositions
08/26/2004WO2004071400A2 Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity
08/26/2004WO2004071388A2 Medicinal compounds
08/26/2004WO2004058164A3 Asthma and allergic inflammation modulators
08/26/2004WO2004050610A3 Modulators of melanocortin receptor
08/26/2004WO2004047744A3 3-heterocyclic benzylamide derivatives as potassium channel openers
08/26/2004WO2004037415A3 Catalyst systems for ethylene oligomerisation to linear alpha olefins
08/26/2004WO2004013094A3 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
08/26/2004WO2004003102A3 Polymerizable, luminescent compounds and mixtures, luminescent polymer materials and their use
08/26/2004US20040167344 Process for producing organotitanium compound and process for addition reaction
08/26/2004US20040167334 Heterocyclic acylsulfimides, processes for their preparation, compositions comprising them and their use as pesticides
08/26/2004US20040167332 Boronic ester and acid compounds, synthesis and uses
08/26/2004US20040167331 To inhibit virulence and reduce antibiotic resistance of mycothiol-producing bacteria
08/26/2004US20040167216 Carbidopa prodrugs and derivatives, and compositions and uses thereof
08/26/2004US20040167183 Protein tyrosine phosphatase inhibitor; antidiabetic agents; hypotensive agents; cardiovascular disorders; inflammatory bowel disorders; antiulcer agents; wound healing agents; anticancer agents
08/26/2004US20040167182 Hydroxamic acid and amide compounds and their use as protease inhibitors
08/26/2004US20040167177 Decyclization an 1,3,5 tiiazine compound with hydrogen halide in presence of a nitrile
08/26/2004US20040167135 Dihydropyrimidines
08/26/2004US20040167131 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
08/26/2004US20040167128 Aminopeptidase inhibitor; vision defects; administering to eye
08/26/2004US20040167126 Such as (2RS,3R)-3-amino-4-cyclohexyl-2-hydroxy-N-phenoxybutanamide; methionine aminopeptidase type 2 inhibitors
08/26/2004US20040167119 2-(aminomethyl) arylamide analgesics
08/26/2004US20040167116 Viricides
08/26/2004US20040167113 Bis-aryl sulfonamides
08/26/2004US20040167018 Palladium catalysts
08/26/2004US20040166585 substituted bis(dicarboxymethylaminopyridines, e.g., {2,2',2'',2'''-{[(carboxymethyl)imino]bis(methylene)-bis {[4-[(4-isothiocyanato)phenyl]ethynyl]pyridine-6,2-diyl}bis(methylenenitrilo)}tetrakis(acetato)}-europium(III).
08/26/2004DE10307751A1 New monoclinic boscalide crystal modification with defined melting point useful as herbicide
08/26/2004DE10306617A1 New organic cyanoborates, used as ionic liquid, non-aqueous electrolyte, phase transfer catalyst or intermediate e.g. for liquid crystal compound, pharmaceutical or plant protection agent, are prepared via alkali metal salt
08/26/2004DE10125567B4 Carbonamid substituierte Phenylharnstoffderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Carboxamide-substituted phenylurea derivatives, processes for their preparation and their use as medicaments
08/26/2004CA2791225A1 Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex
08/26/2004CA2755297A1 Processes for the preparation of n-heteroaryl-n-aryl-amines by reacting an n-aryl carbamic acid ester with a halo-heteroaryl and analogous processes
08/26/2004CA2515856A1 Salts comprising cyanoborate anions
08/26/2004CA2515670A1 Phenylacetamides and their use as glucokinase modulators
08/26/2004CA2515638A1 Novel bicyclic compounds and compositions
08/26/2004CA2511900A1 Cetylpyridinium salt of an anti-inflammatory agent and pharmaceutical compositions containing it
08/25/2004EP1449841A1 New fungicidal compounds
08/25/2004EP1449835A2 Alpha-substituted pyrimidine-thioalkyl and alkylether compounds
08/25/2004EP1449834A2 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
08/25/2004EP1449532A1 Compound [2-(4-chloro-2,6-dimethyl-phenoxy)- 3,6-dimethyl-pyridin-4-yl]- (1-ethyl-propyl)- amine and use as CRF antagonist
08/25/2004EP1448577A1 Rhodium and iridium complexes
08/25/2004EP1448556A1 Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (gsk3 inhibitors)
08/25/2004EP1448539A1 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
08/25/2004EP1448535A1 Benzamide and heteroarylamide as p2x7 receptor antagonists
08/25/2004EP1448534A1 6-membered unsaturated heterocyclic compounds useful for selective inhibition ofthe coagulation cascade
08/25/2004EP1448533A1 Dithiocarbamate derivatives and their use as antibacterial agents
08/25/2004EP1448516A1 Hydroxyethylene compounds with asp2 inhibitory activity
08/25/2004EP1448515A2 Compounds for treatment of inflammation, diabetes and related disorders
08/25/2004EP1448514A1 Novel alpha-oxygenated or alpha-thiolated carboxylic acid phenethylamide derivatives
08/25/2004EP1448513A1 Biphenyl-derivatives as p38-kinase inhibitors
08/25/2004EP1448218A2 Beta-secretase inhibitors and methods of use
08/25/2004EP1448202A1 Combination of a pde4 or pde3/4 inhibitor and an anti-rheumatic drug
08/25/2004EP1448195A1 N-adamantylmethyl derivates and intermediates as pharmaceutical compositions and processes for their preparation
08/25/2004EP1448180A1 Para-amino benzoic acids as integrin antagonists
08/25/2004EP1448176A2 Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion
08/25/2004EP1343764B1 Urea and urethane derivatives as integrin inhibitors
08/25/2004EP1149069B1 Phenylglycine derivatives
08/25/2004EP1087963B1 Inhibitors of glycogen synthase kinase 3
08/25/2004EP1086080B1 Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics
08/25/2004EP0973743B1 Pharmaceutical compositions incorporating aryl substituted olefinic amine compounds
08/25/2004EP0934302B1 Aminophenol derivates
08/25/2004CN1524074A Method for producing 1,3-disubstituted 2-nitroguanidines
08/25/2004CN1524072A Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours
08/25/2004CN1523988A Use of nk-1 receptor antagonists for the treatment of brain, spinal or nerve injury
08/25/2004CN1523015A 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines
08/25/2004CN1522698A Antivirals
08/25/2004CN1163477C Substituted beta-alanine
08/24/2004US6780998 Substituted 2-aminoalkyl-1,4-diaminobenzene compounds and oxidation dye precursor compositions containing same
08/24/2004US6780997 Such as dibenzyl(a,3-o-isopropylidiene-3-hydroxy-4-hydroxymethyl-2-methyl-5-pyridyl) hydroxymethylphosphonate which functions like pyridoxal-5'-phosphate in vivo; drug screening; antidiabetic agents
08/24/2004US6780995 Activated iododerivatives for the treatment of cancer and aids
08/24/2004US6780947 Characterized in that said ligand consists of a mono-imine of 2,6-diacylpyridine
08/24/2004US6780883 Anticholesterol agents; cardiovascular disorders; antilipemic agents; restenosis; dietetics
08/24/2004US6780879 As antitumor agent
08/24/2004US6780874 Autoimmune disease; antiinflammatory agents; antiproliferative agent
08/24/2004US6780858 Hydroxyamidines and related compounds
08/24/2004CA2105723C Method of controlling insects
08/24/2004CA2065051C Improved use of .beta.2 bronchodilator drugs
08/19/2004WO2004069823A1 Inhibitors of histone deacetylase
08/19/2004WO2004069808A1 Acrylamide derivative, process for producing the same, and use
08/19/2004WO2004069805A1 Bis(hetero)aryl carboxamide derivatives for use as pgi2 antagonists
08/19/2004WO2004069803A2 Mono-acylated o-phenylendiamines derivatives and their use against cancer
08/19/2004WO2004069802A1 Process for producing 2-amino-3-substituted pyridine
08/19/2004WO2004069801A1 Metal ion chelators and therapeutic use thereof
08/19/2004WO2004069794A2 New arylpiperazinyl compounds
08/19/2004WO2004069788A1 Carboxylic acid compounds
08/19/2004WO2004062571A3 Substantially pure cilostazol and processes for making same
08/19/2004WO2004056365A3 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone
08/19/2004WO2004050620A3 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex
08/19/2004WO2004048335A3 Mandelic acid derivatives